Stock COLUMBIA LABORATORIES INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Columbia Laboratories Inc. Nasdaq

Equities

US1977791011

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Columbia Laboratories Inc.

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Juniper Pharmaceuticals : Reports Second Quarter 2018 Financial and Operating Results
PR
Juniper Pharmaceuticals : Signs Definitive Agreement to be Acquired by Catalent, Inc. for $11.50 Per Share in Cash
PR
Juniper Pharmaceuticals : Reports First Quarter 2018 Financial and Operating Results
PR
Juniper Pharmaceuticals : to Report First Quarter 2018 Results on May 10, 2018
PR
Juniper Pharmaceuticals : Licenses Intravaginal Ring (IVR) Platform to Daré Bioscience
PR
Juniper Pharmaceuticals : Appoints Richard Messina to Board of Directors
PR
Juniper Pharmaceuticals : Reports Full-Year 2017 Financial and Operating Results
PR
Juniper Pharmaceuticals : to Report Fourth Quarter and Year-End 2017 Results on March 8, 2018
PR
Juniper Pharmaceuticals : to Explore Strategic Alternatives
PR
Juniper Pharmaceuticals : Announces 4.5-Year Extension through 2024 of CRINONE® Supply Agreement with Merck KGaA, Darmstadt, Germany
PR
Juniper Pharmaceuticals : Outlines Strategic Priorities for 2018 and Reports Recent Portfolio Progress
PR
Juniper Pharmaceuticals : Reports Third Quarter 2017 Financial and Operating Results
PR
Juniper Pharmaceuticals : to Report Third Quarter 2017 Results on November 2, 2017
PR
Juniper Pharmaceuticals : Announces Strategic Reprioritization
PR
Juniper Pharmaceuticals : Appoints Jennifer Good to Board of Directors
PR
Juniper Pharmaceuticals : Reports Second Quarter 2017 Financial and Operating Results
PR
Juniper Pharmaceuticals : to Report Second Quarter 2017 Results on August 3, 2017
PR
Juniper Pharmaceuticals : Announces Results of 2017 Annual Meeting
PR
Juniper Pharmaceuticals : Reports First Quarter 2017 Financial and Operating Results
PR
Juniper Pharmaceuticals : to Report First Quarter 2017 Results on May 4, 2017
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. Stock
  5. News Columbia Laboratories Inc.